ATE405646T1 - Ein verfahren zum auffinden vom prostatakrebs - Google Patents

Ein verfahren zum auffinden vom prostatakrebs

Info

Publication number
ATE405646T1
ATE405646T1 AT00978222T AT00978222T ATE405646T1 AT E405646 T1 ATE405646 T1 AT E405646T1 AT 00978222 T AT00978222 T AT 00978222T AT 00978222 T AT00978222 T AT 00978222T AT E405646 T1 ATE405646 T1 AT E405646T1
Authority
AT
Austria
Prior art keywords
prostate cancer
detecting prostate
detecting
seq
subject
Prior art date
Application number
AT00978222T
Other languages
English (en)
Inventor
Robert Getzenberg
Original Assignee
Univ Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pittsburgh filed Critical Univ Pittsburgh
Application granted granted Critical
Publication of ATE405646T1 publication Critical patent/ATE405646T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
AT00978222T 1999-10-15 2000-10-16 Ein verfahren zum auffinden vom prostatakrebs ATE405646T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/418,839 US6617432B1 (en) 1999-10-15 1999-10-15 Nuclear matrix proteins polynucleotide sequences encoding them and their use

Publications (1)

Publication Number Publication Date
ATE405646T1 true ATE405646T1 (de) 2008-09-15

Family

ID=23659754

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00978222T ATE405646T1 (de) 1999-10-15 2000-10-16 Ein verfahren zum auffinden vom prostatakrebs

Country Status (8)

Country Link
US (3) US6617432B1 (de)
EP (2) EP1228210B1 (de)
JP (1) JP2003512391A (de)
AT (1) ATE405646T1 (de)
AU (1) AU784404B2 (de)
CA (1) CA2387864A1 (de)
DE (1) DE60040010D1 (de)
WO (1) WO2001029218A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030228640A1 (en) 1999-10-15 2003-12-11 University Of Pittsburgh Nuclear matrix proteins, polynucleotide sequences encoding them, and their use
JP4560314B2 (ja) * 2004-03-17 2010-10-13 ジェイファーマ株式会社 中性アミノ酸トランスポーターによる癌の検出法、及びそのためのキット

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308835A (en) * 1984-07-09 1994-05-03 Praxis Biologics, Inc. Production of the E. coli LT-B enterotoxin subunit
US5273877A (en) * 1985-12-24 1993-12-28 Massachusetts Institute Of Technology Non-histological cell type determination
US4882268A (en) * 1985-12-24 1989-11-21 Massachusetts Institute Of Technology Method for determining tissue of origin and degree of malignancy of tumor cells
DE4012454C1 (de) * 1990-04-19 1991-08-08 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V., 8000 Muenchen, De
ATE191567T1 (de) * 1991-10-31 2000-04-15 Matritech Inc Bestimmung von nukleären matrixproteinen in flüssigkeiten
AU681855B2 (en) 1992-06-22 1997-09-11 Matritech, Inc. Novel malignant cell type markers of the interior nuclear matrix
CA2155645A1 (en) 1993-02-09 1994-08-18 Donald S. Coffey Nuclear matrix proteins
US5547928A (en) * 1993-12-17 1996-08-20 Matritech, Inc. Methods and compositions for the detection of colon cancers
AUPM885194A0 (en) * 1994-10-14 1994-11-10 Council Of The Queensland Institute Of Medical Research, The Synthetic peptides and vaccines comprising same
ES2219699T3 (es) * 1995-10-19 2004-12-01 Bristol-Myers Squibb Company Anticuerpo monoclonal br110 y usos del mismo.
MX9705025A (es) * 1995-11-03 1998-05-31 Robert H Getzenberg Proteinas de matriz nuclear de vejiga y su uso para detectar y tratar trastornos proliferativos celulares.
US20030228640A1 (en) * 1999-10-15 2003-12-11 University Of Pittsburgh Nuclear matrix proteins, polynucleotide sequences encoding them, and their use

Also Published As

Publication number Publication date
EP1702984A3 (de) 2006-10-18
JP2003512391A (ja) 2003-04-02
EP1228210A2 (de) 2002-08-07
CA2387864A1 (en) 2001-04-26
WO2001029218A2 (en) 2001-04-26
EP1702984A2 (de) 2006-09-20
AU1570301A (en) 2001-04-30
US6617432B1 (en) 2003-09-09
WO2001029218A3 (en) 2002-03-07
US20030170754A1 (en) 2003-09-11
EP1228210B1 (de) 2008-08-20
US20050181418A1 (en) 2005-08-18
AU784404B2 (en) 2006-03-30
DE60040010D1 (de) 2008-10-02

Similar Documents

Publication Publication Date Title
ATE440868T1 (de) Monoklonaler antikírper gegen ein prion protein und dessen verwendung zum nachweis von prionen
ATE250143T1 (de) Verfahren und vorrichtung zum nachweis und zur quantifizierung von biomolekülen
ATE310955T1 (de) Zusammensetzungen und verfahren zum nachweis und zur behandlung von mit chemokinrezeptoren verbundenen krankheiten
DE59903915D1 (de) Verfahren zur frühen diagnose von carcinomen
DK2230299T3 (da) Hidtil ukendt cytokin ZCYTOR17-ligand
DE69937835D1 (de) Antikörper für apoptosemarker und anwendungsverfahren
DE69932813D1 (de) Nukleinsäurebindungsproteine
PL1625163T3 (pl) Sposoby wykrywania proBMP przeciwciałem monoklonalnym wiążącym się z aminokwasami 38-43
ATE554106T1 (de) Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung
ATE325344T1 (de) Zielsequenzen für synthetische moleküle und verfahren für deren verwendung
DE60237455D1 (de) Verfahren zur quantifizierung von denaturiertem lipoprotein
DK1336109T3 (da) Kit og fremgangsmåde til at påvise proteinet EMS-1
WO2002004949A3 (en) Reagents and methods for identification of binding agents
WO2000035950A3 (en) Reagents and methods useful for detecting diseases of the breast
DE60038363D1 (de) Detektion von kleinen molekülen mit piezo-elektrischem sensor
MXPA01008605A (es) Proteina de enlace del antigeno goodpasture.
ATE360034T1 (de) Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft
HK1011560A1 (en) Method of diagnosing and treating epithelioma
ATE405646T1 (de) Ein verfahren zum auffinden vom prostatakrebs
ATE335816T1 (de) Verfahren zum nachweis prokaryontischer dna
DE69942215D1 (de) Verfahren zum immunochemischen Testen des Anti-HM1.24-Antikörpers
DE69731845D1 (de) Verfahren zum nachweis von protein s
DE69817338D1 (de) Verfahren zum nachweis von autoimmun-pathologien
DK0923644T3 (da) G-koblet receptor, der udviser selektiv selektivitet for ATP
DK1129191T3 (da) Fremgangsmåder til diagnosticering eller behandling af neurologiske sygdomme

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties